Clinicopathological and immunohistochemical analysis of gastrointestinal stromal tumor

World Journal of Gastroenterology

Volumn 12, Issue 26, 2006, Pages 4161-4165

  Liu, Feng Yu ^a   Qi, Ji Ping ^a   Xu, Feng Lin ^a   Wu, Ai Ping ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Bax; Gastrointestinal stromal tumor; p21WAF1

Indexed keywords

CD34 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1; DESMIN; PROTEIN BAX; PROTEIN P21; PROTEIN S 100; STEM CELL FACTOR RECEPTOR; VIMENTIN;

ADULT; AGED; ARTICLE; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; EPITHELIOID CELL; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERSTITIAL CELL OF CAJAL; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MYENTERIC PLEXUS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPINDLE CELL; STATISTICAL SIGNIFICANCE; TUMOR BLEEDING; TUMOR LOCALIZATION; TUMOR NECROSIS; TUMOR VOLUME;

EID: 33748596056     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i26.4161     Document Type: Article

References (29)

1. Duensing A, Heinrich MC, Fletcher CD, Fletcher JA. Biology of gastrointestinal stromal tumors: KIT mutations and beyond. Cancer Invest 2004; 22: 106-116
2. Kim TW, Lee H, Kang YK, Choe MS, Ryu MH, Chang HM, Kim JS, Yook JH, Kim BS, Lee JS. Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors. Clin Cancer Res 2004; 10: 3076-3081
3. Gelen T, Elpek GO, Aksoy NH, Ogus M, Keles N. p27 Labeling index and proliferation in gastrointestinal stromal tumors: correlations with clinicopathologic factors and recurrence. Jpn J Clin Oncol 2003; 33: 346-352
4. Tornoczky T, Kover E, Pajor L. Frequent occurrence of low grade cases among metastatic gastrointestinal stromal tumours. J Clin Pathol 2003; 56: 363-367
5. Haber MH, Gattuso P, Spitz DJ, David O. Differential diagnosis in surgical pathology. 1st ed. Beijing: Health Science Asia, Elsevier Science, 2002: 188-192
6. Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983; 7: 507-519
7. Liu P, Na J, Wang Y, He Q, Zhang Y, Tang X, Zou W. Study of gastrointestinal stromal tumors by light microscopy, electron microscopy and immunohistochemistry. Zhonghua Bingli Xue Zazhi 2002; 31: 199-203
8. Bucher P, Villiger P, Egger JF, Bucher LH, Morel P. Management of gastrointestinal stromal tumors: from diagnosis to treatment. Swiss Med Wkly 2004; 134: 145-153
9. Ray-Coquard I, Le Cesne A, Michallet V, Boukovinas I, Ranchere D, Thiesse P, Baty V, Blay JY. Gastro-intestinal stromal tumors: news and comments. Bull Cancer 2003; 90: 69-76
10. Wang L, Vargas H, French SW. Cellular origin of gastrointestinal stromal tumors: a study of 27 cases. Arch Pathol Lab Med 2000; 124: 1471-1475
11. Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer 2002; 38 Suppl 5: S39-S51
12. Ma CK, Amin MB, Kintanar E, Linden MD, Zarbo RJ. Immunohistologic characterization of gastrointestinal stromal tumors: a study of 82 cases compared with 11 cases of leiomyomas. Mod Pathol 1993; 6: 139-144
13. Boggino HE, Fernandez MP, Logrono R. Cytomorphology of gastrointestinal stromal tumor: diagnostic role of aspiration cytology, core biopsy, and immunochemistry. Diagn Cytopathol 2000; 23: 156-160
14. Liu X, Ma D, Wit L, Bai C, Hu H. Expression and clinical significance of c-kit oncogene in gastrointestinal stromal tumors. Zhonghua Waike Zazhi 2002; 40: 277-279
15. Hou Y, Wang J, Zhu X, Du X, Sun M, Zheng A. A clinicopathologic and immunohistochemical study on 76 cases of gastrointestinal stromal tumors. Zhonghua Bingli Xue Zazhi 2002; 31: 20-25
16. Kim MK, Lee JK, Park ET, Lee SH, Seol SY, Chang JM, Kang MS, Yoon HK. Gastrointestinal stromal tumors: clinical, pathologic features and effectiveness of new diagnostic criteria. Korean J Gastroenterol 2004; 43: 341-348
17. Okamoto K, Kato S, Arima N, Fujii T, Morimatsu M, Imaizumi T. Cyclin-dependent kinase inhibitor, p21Waf1, regulates vascular smooth muscle cell hypertrophy. Hypertens Res 2004; 27: 283-291
18. Pindzola JA, Palazzo JP, Kovatich AJ, Tuma B, Nobel M. Expression of p21WAF1/CIP1 in soft tissue sarcomas: a comparative immunohistochemical study with p53 and Ki-67. Pathol Res Pract 1998; 194: 685-691
19. Migaldi M, Sgambato A, Garagnani L, Ardito R, Ferrari P, De Gaetani C, Cittadini A, Trentini GP. Loss of p21Waf1 expression is a strong predictor of reduced survival in primary superficial bladder cancers. Clin Cancer Res 2000; 6: 3131-3138
20. van der Woude CJ, Kleibeuker JH, Tiebosch AT, Homan M, Beuving A, Jansen PL, Moshage H. Diffuse and intestinal type gastric carcinomas differ in their expression of apoptosis related proteins. J Clin Pathol 2003; 56: 699-702
21. Wheaton S, Netser J, Guinee D, Rahn M, Perkins S. Bcl-2 and bax protein expression in indolent versus aggressive B-cell non-Hodgkin's lymphomas. Hum Pathol 1998; 29: 820-825
22. Jansson A, Sun XF. Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer. J Clin Oncol 2002; 20: 811-816
23. Chao H, Sun J, Lu S. Bax gene expression in endometrial carcinoma. Zhonghua Zhongliu Zazhi 2001; 23: 214-216
24. Liu Y, Chen C, Chen C, Hsieh H, Chang C, Shyu J, Yen C, Harn H. Apoptosis and Fas-ligand expression correlate to the histopathological grade of gastric smooth muscle tumors. J Surg Res 2001; 95: 92-98
25. Noguchi T, Sato T, Takeno S, Uchida Y, Kashima K, Yokoyama S, Muller W. Biological analysis of gastrointestinal stromal tumors. Oncol Rep 2002; 9: 1277-1282
26. Yang F, Wang W. Effects of overexpression of p21WAF1/CIP1 on the malignant phenotype and apoptosis of human hepatocellular carcinoma cells. Zhonghua Zhongliu Zazhi 1999; 21: 99-101
27. Matsushita H, Morishita R, Kida I, Aoki M, Hayashi S, Tomita N, Yamamoto K, Moriguchi A, Noda A, Kaneda Y, Higaki J, Ogihara T. Inhibition of growth of human vascular smooth muscle cells by overexpression of p21 gene through induction of apoptosis. Hypertension 1998; 31: 493-498
28. Rau B, Sturm I, Lage H, Berger S, Schneider U, Hauptmann S, Wust P, Riess H, Schlag PM, Dorken B, Daniel PT. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy. J Clin Oncol 2003; 21: 3391-3401
29. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002; 1: 639-649